Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor model.

Autor: Waterhouse, Dawn N.1,2 dwater@bccancer.bc.ca, Gelmon, Karen A.1, Masin, Dana1, Bally, Marcel B.1,2,3
Zdroj: Journal of Experimental Therapeutics & Oncology. Sep/Oct2003, Vol. 3 Issue 5, p261-271. 11p.
Databáze: Academic Search Ultimate